{"name":"Innolake Biopharm","slug":"innolake-biopharm","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"ILB-3101","genericName":"ILB-3101","slug":"ilb-3101","indication":"Other","status":"phase_1"},{"name":"ILB2109","genericName":"ILB2109","slug":"ilb2109","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ILB-3101","genericName":"ILB-3101","slug":"ilb-3101","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"ILB2109","genericName":"ILB2109","slug":"ilb2109","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxPN1phMUktNGg5YjhBLVZHMGlvbFhxY1RFV09iRTRhejROVkNMb0IxRFNIU3otNHBpYjFOMUxvVjBHaDh0Y0w1R3lWLVZtNkYtMFNXUnpVdktRY2lpdjBxQnBTZ19NZGdITWFMWG9UNEE2Ukw0YWVvLV9tODZqMUlVWUV2RDdhbDg?oc=5","date":"2026-01-23","type":"deal","source":"The Pharma Letter","summary":"Ellipses in-licenses ADC from China - The Pharma Letter","headline":"Ellipses in-licenses ADC from China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNd29peEtBTk1JZW1Jc3FiQUpCeS1qMVhCaVdJb1JNNE50Tl9UN3A4eDJ3bHpxVDJ5RW8wOVhPNVpqWmZNUDVra2dCdTREdEV2ZGlsNHFjOUlUTHo3TjNqRVh3MTNsdFNmR2VSWjB0dmVWQVVrWlNJZlR6ZzJ0SlhHUWNkNU9PZmR6WXdzRVNEYm9SYzF6WUNteWtpRlVsWjgxNGdTVlJwZDRrS2lWM0djNWpJQ2tZYjlZRmU1V1g2bw?oc=5","date":"2026-01-23","type":"deal","source":"European Biotechnology Magazine","summary":"London-based Ellipses licenses another oncologic asset from Chinese pharma - European Biotechnology Magazine","headline":"London-based Ellipses licenses another oncologic asset from Chinese pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPTVFMUVA1RFJZcUhfQmppRFFNQW5LMmdHUG5PNGVRVTFuNnVaQXYyOGdWdkF2dFdqQVNsNlZfOFhIbnBVRkMzeTI2Nnlfa0E2QUpQWFhxeFdiZDZ1akdxdlphV1RvMWJYY2IxaTBXbTJTeWRsclg4Z2Jncm4xQmxWSjBfWm9JUXBicENuSmNrcmh6ZGNfd2lWa2NLbms5bE1SZGsyQk5SMGxWaW52VC1IYmhoV0tWQQ?oc=5","date":"2026-01-23","type":"deal","source":"BioSpace","summary":"Ellipses In-Licenses First-in-Class B7H3 Antibody Drug Conjugate From China - BioSpace","headline":"Ellipses In-Licenses First-in-Class B7H3 Antibody Drug Conjugate From China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQdGE4YVZUQS1LOXo3R2xFVnFlck1NbzMyeHlla0dSTzVXMm1TQTlMWWlwTlVfcFNESVFxUFc5dW1LdUJYLWIwTE51eV9IRGM4NWU3Zko4eHBkY1h6ZVdmcmJGcEJqZmlOczAtVm4wV0YxLTU0OWJSdldOUnR6QjhzTjdFYi1NdHVlU0dxSFdvZFU5UUxqUWN6NEt4akFGWkZlSF9pWg?oc=5","date":"2026-01-23","type":"pipeline","source":"BioWorld News","summary":"Asia roundup: Shionogi ups Viiv stake, Fosun spinoff plans, more - BioWorld News","headline":"Asia roundup: Shionogi ups Viiv stake, Fosun spinoff plans, more","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE5XWUJWOURpQ2RjblNPZlVWX2NWYTRJNHZPVWdlNnhUZXF3Z3ZmRnMtRmRjWm5QN0xNVUZ6T0V2czdWbk5RZEVMLXN1VFg5aEpTU1ktUnRmUW9UM3VNWDcxSEZONzZpS1R4OWFHNzVCVng3Z1J5YmNKV1FkY1NQems?oc=5","date":"2026-01-22","type":"trial","source":"Oncology Pipeline","summary":"Ellipses Pharma widens its orbit | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"Ellipses Pharma widens its orbit | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE1kVEE0Q0ZGcHdvTHh2ZEE3aEhXa2FNUEZqck8zVjRaMEF1R2VfUW9QbnllVkcxYzM3LVBFZXhWbXpMdTNBZlh3QmtXQ1pfVkZSX0ZMNWVIVDVONzFxOGhZcg?oc=5","date":"2026-01-21","type":"pipeline","source":"Oncodaily","summary":"Ellipses Pharma Announces Exclusive Licence Agreement with Innolake Biopharm to Develop a First-in-Class B7H3-Targeted ADC - Oncodaily","headline":"Ellipses Pharma Announces Exclusive Licence Agreement with Innolake Biopharm to Develop a First-in-Class B7H3-Targeted A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPU05zOERIZTlMS2dGM3FMOXVvOV9Kd0lVNXNMX1l6eVB3VExHcEdIMFpnNkQtdDhLX2tBd29rU1puVlI3Y2hLbU1kQmtwMVdwUG1Va2FpT1JXdmJRRUtCRW9fb2lGXzl5OXB0VmQ4bXg3d2FKX3ZncDNoWHZlSXpJYXhKNGRIc3ZfdDIwcTJHRXpHNnE4NUhmNXFaVQ?oc=5","date":"2026-01-05","type":"patent","source":"BioWorld News","summary":"Innolake Biopharm patents new antibody-drug conjugates - BioWorld News","headline":"Innolake Biopharm patents new antibody-drug conjugates","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}